D-cycloserine

D-cycloserine is a lipid of Polyketides (PK) class. D-cycloserine is associated with abnormalities such as Inflammatory disorder, Asthma, Rheumatoid Arthritis, Multiple Sclerosis and Inflammatory Bowel Diseases. The involved functions are known as Cellular Infiltration, Vascular Permeability, Stimulus, antagonists and Kinase Inhibitors [MoA]. D-cycloserine often locates in Tissue membrane, Body tissue, Protoplasm, Endothelium and Cell Wall. The associated genes with D-cycloserine are Genome, serine O-sulfate, Polypeptides, alpha-aminobutyric acid, (S)-isomer and Genes, Reporter. The related lipids are Sphingolipids, Fatty Acids, Sterols, 25-hydroxycholesterol and Fatty Acids, Unsaturated.

Cross Reference

Introduction

To understand associated biological information of D-cycloserine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with D-cycloserine?

D-cycloserine is suspected in Tuberculosis, Inflammatory disorder, Asthma, Rheumatoid Arthritis, Multiple Sclerosis, Inflammatory Bowel Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with D-cycloserine

MeSH term MeSH ID Detail
Starvation D013217 47 associated lipids
Tuberculosis, Multidrug-Resistant D018088 6 associated lipids
Total 2

PubChem Associated disorders and diseases

What pathways are associated with D-cycloserine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with D-cycloserine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with D-cycloserine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with D-cycloserine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with D-cycloserine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with D-cycloserine?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with D-cycloserine

Download all related citations
Per page 10 20 50 100 | Total 2271
Authors Title Published Journal PubMed Link
Nair S and Baron H Tryptophan metabolism in tuberculosis. 1973 Am. Rev. Respir. Dis. pmid:4741891
BOWER G SKIN RASH, HEPATITIS, AND HEMOLYTIC ANEMIA CAUSED BY PARA-AMINOSALICYLIC ACID. 1964 Am. Rev. Respir. Dis. pmid:14129347
Fischer DA et al. Re-treatment of patients with isoniazid-resistant tuberculosis. Analysis and follow-up of 146 cases. 1968 Am. Rev. Respir. Dis. pmid:5638494
Woodley CL and Kilburn JO In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiro-piperidyl rifamycin. 1982 Am. Rev. Respir. Dis. pmid:6289711
David HL Effect of O-carbamyl-D-serine on the growth of mycobacterium tuberculosis. 1970 Am. Rev. Respir. Dis. pmid:4987793
CHAVES AD et al. ETHIONAMIDE-CYCLOSERINE THERAPY FOR AMBULATORY PATIENTS WITH PULMONARY TUBERCULOSIS UNRESPONSIVE TO STANDARD DRUGS. 1963 Am. Rev. Respir. Dis. pmid:14045232
Heifets L Qualitative and quantitative drug-susceptibility tests in mycobacteriology. 1988 Am. Rev. Respir. Dis. pmid:3195815
Pines A Results after retreatment of advanced pulmonary tuberculosis with rifampin and other drugs. 1971 Am. Rev. Respir. Dis. pmid:4104090
Hawkins JE and McClean VR Effect of d-alanine on cycloserine blood levels in laboratory animals. 1966 Am. Rev. Respir. Dis. pmid:5910683
WOLINSKY E and KAPUR VN Evaluation of cycloserine with high dosage of isoniazid in chronic treatment-failure pulmonary tuberculosis. 1959 Am. Rev. Respir. Dis. pmid:13845748
Hawkins JE and McClean VR Comparative studies of cycloserine inhibition of mycobacteria. 1966 Am. Rev. Respir. Dis. pmid:4956240
HOEPRICH PD ALANINE--CYCLOSERINE ANTAGONISM. V. OCCURRENCE AMONG ACID-FAST BACILLI. 1964 Am. Rev. Respir. Dis. pmid:14225973
HOK TT and SENG TK A COMPARATIVE STUDY OF THE SUSCEPTIBILITY TO STREPTOMYCIN, CYCLOSERINE, VIOMYCIN, AND KANAMYCIN OF TUBERCLE BACILLI FROM 100 PATIENTS NEVER TREATED WITH CYCLOSERINE, VIOMYCIN, OR KANAMYCIN. 1964 Am. Rev. Respir. Dis. pmid:14233803
Ethambutol in re-treatment of pulmonary tuberculosis. 1968 Am. Rev. Respir. Dis. pmid:4300827
Corpe RF and Blalock FA A continuing study of patients with "open negative" status at Battey State Hospital. 1968 Am. Rev. Respir. Dis. pmid:4301382
Ramirez J Pulmonary alveolar proteinosis. Treatment in a case complicated by tuberculosis. 1967 Am. Rev. Respir. Dis. pmid:6066626
SCHLESS JM et al. THE USE OF ETHIONAMIDE IN COMBINED DRUG REGIMENS IN THE RE-TREATMENT OF ISONIAZID-RESISTANT PULMONARY TUBERCULOSIS. 1965 Am. Rev. Respir. Dis. pmid:14280946
RIVERA E and BROWNING RH Re-treatment therapy with cycloserine-pyrazinamide. Response in cavity closure and disappearance of tubercle bacilli from sputum. 1962 Am. Rev. Respir. Dis. pmid:13974134
Steiner P et al. Primary drug resistance in children. Drug susceptibility of strains of M. tuberculosis isolated from children during the years 1969 to 1972 at the Kings County Hospital Medical Center of Brooklyn. 1974 Am. Rev. Respir. Dis. pmid:4209361
Steiner P et al. Primary isoniazid-resistant tuberculosis in children. Clinical features, strain resistance, treatment, and outcome in 26 children treated at Kings County Medical Center of Brooklyn between the years 1961 and 1972. 1974 Am. Rev. Respir. Dis. pmid:4213311
CONN HO et al. ETHIONAMIDE-INDUCED HEPATITIS. A REVIEW WITH A REPORT OF AN ADDITIONAL CASE. 1964 Am. Rev. Respir. Dis. pmid:14221666
Kuze F Experimental chemotherapy in chronic Mycobacterium avium-intracellulare infection of mice. 1984 Am. Rev. Respir. Dis. pmid:6703503
David HL Susceptibility of mycobacterium intracellulare to O-carbamyl-D-serine. 1970 Am. Rev. Respir. Dis. pmid:5427392
Yaroshenko DV et al. Development and validation of a LC-MS/MS method for D-cycloserine determination in human plasma for bioequivalence study. 2014 Anal Bioanal Chem pmid:24337137
Mao Z et al. A simplified LC-MS/MS method for rapid determination of cycloserine in small-volume human plasma using protein precipitation coupled with dilution techniques to overcome matrix effects and its application to a pharmacokinetic study. 2017 Anal Bioanal Chem pmid:28224247
Jamindar D and Gutheil WG A liquid chromatography-tandem mass spectrometry assay for Marfey's derivatives of L-Ala, D-Ala, and D-Ala-D-Ala: application to the in vivo confirmation of alanine racemase as the target of cycloserine in Escherichia coli. 2010 Anal. Biochem. pmid:19748470
el-Sayed L et al. Spectrophotometric and spectrofluorimetric determination of cycloserine with p-benzoquinone. 1986 Analyst pmid:3766980
Fountoulakis KN The emerging modern face of mood disorders: a didactic editorial with a detailed presentation of data and definitions. 2010 Ann Gen Psychiatry pmid:20385020
Nusca A et al. [Tryptose sulphite cycloserine agar for the recovery of Clostridium perfringens in surface waters: a study of different modes of utilization]. 2007 Jan-Feb Ann Ig pmid:17405507
Hermier J et al. [Role of nicotinamide adenine dinucleotide dehydrogenases in initial phase of spore germination in Bacillus subtilis]. 1970 Ann Inst Pasteur (Paris) pmid:4987262
GROSSET J and CANETTI G [Incidence of wild strains of Mycobacterium tuberculosis in variants resistant to minor antibiotics (p-aminosalicylic acid, ethionamide, cycloserine, viomycin, kanamycin)]. 1962 Ann Inst Pasteur (Paris) pmid:13902273
TISON F et al. [UNSUITABILITY OF THE BASIC COLETSOS MEDIUM FOR THE MEASUREMENT OF SENSITIVITY TO CYCLOSERINE. INACTIVATION OF CYCLOSERINE BY SODIUM PYRUVATE]. 1963 Ann Inst Pasteur Lille pmid:14202532
LUCCHESI M et al. [ANTIBACTERIAL TREATMENT IN PATIENTS AFFLICTED WITH PULMONARY TUBERCULOSIS CAUSED BY MYCOBACTERIA RESISTANT TO THE MAJOR CHEMO-ANTIBIOTICS]. 1963 Ann Ist Carlo Forlanini pmid:14122048
Lucchesi M et al. [On some aspects of antimycobacterial activity in vitro of cycloserine and terizidone]. 1968 Ann Ist Carlo Forlanini pmid:4981145
DE SIMONI G and CATTANEO C [Various biological tests on several groups of subjects with tuberculosis subjected respectively to monotherapy with isoniazid, viomycin, pyrazinamide, cycloserine, ethioniamide and kanamycin]. 1962 Ann Ist Carlo Forlanini pmid:14026068
Lucchesi M et al. [Drug sensitivity of the so-called atypical mycobacteria]. 1968 Ann Ist Carlo Forlanini pmid:4314838
MORELLINI M et al. [The activity of cycloserine on "paratubercular" mycobacteria]. 1960 Ann Ist Carlo Forlanini pmid:13772514
Boccitto G et al. [Behavior of certain biologic parameters of hepatic and renal function during therapy with rifomycin B diethylamide (rifamide) administered by venous infusion]. 1968 Ann Ist Carlo Forlanini pmid:5735705
MERENDA P and FORTUNI M [On the diagnostic possibilities of cycloserine hyperthermia and aldolase activity of the serum in patients with solitary lung nodules]. 1962 Ann Ital Chir pmid:13934961
Rajtar-Leontiew Z [Effect of isoniazid on pyridoxine (vitamin B6) metabolism in children. Experimental study]. 1970 Ann Pediatr (Paris) pmid:5513157
Vamvakides A [Inactivity of imipramine in the forced swimming test on old mice or on young mice undergone chronic glycinergic treatment]. 1996 Ann Pharm Fr pmid:9008899
Peloquin CA et al. Pharmacokinetics of para-aminosalicylic acid granules under four dosing conditions. 2001 Ann Pharmacother pmid:11724078
FLOCH H and FLOCH T [THE CHEMOTHERAPY OF LEPROSY]. 1964 Ann Soc Belges Med Trop Parasitol Mycol pmid:14211530
Srednicka-Zajac D et al. [Resistance of tubercle bacilli to cycloserine, viomycin and ethionamide in patients suffering from pulmonary tuberculosis]. 1967 Ann Univ Mariae Curie Sklodowska Med pmid:4308440
van Dongen JT et al. Transcript and metabolite profiling of the adaptive response to mild decreases in oxygen concentration in the roots of arabidopsis plants. 2009 Ann. Bot. pmid:18660497
Venho VM and Koskinen R The effect of pyrazinamide, rifampicin and cycloserine on the blood levels and urinary excretion of isoniazid. 1971 Ann. Clin. Res. pmid:5156629
Aukee S et al. Drug absorption in patients with T-tube after cholecystectomy. 1975 Ann. Clin. Res. pmid:1155910
Murty MV and Venkitasubramanian TA Evidence for the synthesis of peptidoglycan by spheroplasts of Mycobacterium smegmatis ATCC-14468. 1984 May-Jun Ann. Microbiol. (Paris) pmid:6465738
Iandolo JJ Repair of stress-induced macromolecular alterations in S. aureus. 1974 Ann. N. Y. Acad. Sci. pmid:4529248
Cohen AC Pyridoxine in the prevention and treatment of convulsions and neurotoxicity due to cycloserine. 1969 Ann. N. Y. Acad. Sci. pmid:5262029
Jones RW et al. Effects of NMDA modulation in scopolamine dementia. 1991 Ann. N. Y. Acad. Sci. pmid:1837979
Kantak KM and Nic Dhonnchadha BÁ Pharmacological enhancement of drug cue extinction learning: translational challenges. 2011 Ann. N. Y. Acad. Sci. pmid:21272016
Pyle MM Ethambutol in the retreatment and primary treatment of tuberculosis: a four-year clinical investigation. 1966 Ann. N. Y. Acad. Sci. pmid:5220243
Kass I Kanamycin in the therapy of pulmonary tuberculosis in the United States. 1966 Ann. N. Y. Acad. Sci. pmid:4960375
Dye WE Bacteriology of tuberculosis with special reference to kanamycin and related drugs. 1966 Ann. N. Y. Acad. Sci. pmid:4290030
Rapp A et al. Treatment of pediatric anxiety disorders. 2013 Ann. N. Y. Acad. Sci. pmid:24279893
Kutt H Biochemical and genetic factors regulating dilantin metabolism in man. 1971 Ann. N. Y. Acad. Sci. pmid:4105796
Fonnum F et al. Role of glutamate and glutamate receptors in memory function and Alzheimer's disease. 1995 Ann. N. Y. Acad. Sci. pmid:7611704
Tomasz A The role of autolysins in cell death. 1974 Ann. N. Y. Acad. Sci. pmid:4153141
de Repentigny J and Mathieu LG Metabolism and pathogenicity in Staphylococcus single and mixed cultures and infections. 1974 Ann. N. Y. Acad. Sci. pmid:4213698
Sanders WE and Sanders CC Toxicity of antibacterial agents: mechanism of action on mammalian cells. 1979 Annu. Rev. Pharmacol. Toxicol. pmid:222202
Gallen CS Isoxyl: a review of the results of its use over a five-year period in the tuberculosis field service of a large urban area. 1970 Antibiot Chemother pmid:5535610
Urbancik B Clinical experience with Myambutol in the treatment of polyresistant chronic tuberculosis. 1970 Antibiot Chemother pmid:5535614
Böszörményi M Report on experiences with ethambutol. 1970 Antibiot Chemother pmid:5535615
Goldman S et al. Clinical and bacteriological results with Myambutol. 1970 Antibiot Chemother pmid:4332036
Heise A et al. Evaluation of results of chemotherapy in tuberculosis with special consideration of ethambutol. 1970 Antibiot Chemother pmid:4332037
Böszörményi M Controlled clinical trials with Isoxyl. 1970 Antibiot Chemother pmid:4943578
Krivinka R and Tousek J The first clinical experiences with ethambutol in chronic pulmonary tuberculosis and basilar meningitis. 1970 Antibiot Chemother pmid:4108889
Kittel H Combination treatment with capreomycin of pretreated cavernous pulmonary tuberculosis. 1970 Antibiot Chemother pmid:4108894
Schütz I et al. The combination of ethambutol, capreomycin and a third drug in chronic pulmonary tuberculosis with bacterial polyresistance. 1970 Antibiot Chemother pmid:4108895
Protivinsky R Cycloserine. 1971 Antibiot Chemother (1971) pmid:5006234
HANNGREN H et al. An autoradiographic study of the distribution of tritium-labeled cycloserine in mice. 1962 Antibiot Chemother (Northfield) pmid:13904388
Sokolova GB et al. [Russian cycloserine in complex therapy of drug resistant tuberculosis]. 2008 Antibiot. Khimioter. pmid:19069180
Kunichan AD et al. [Effect of glutoxim in the combination with antitubercular agents of the second choice on the growth of drug resistant Mycobacteria tuberculosis in the cultured murine lung tissue]. 2002 Antibiot. Khimioter. pmid:12422643
Sokolova GB et al. [Rezonizat and cycloserine in complex therapy of drug resistant tuberculosis (comparative studies)]. 2008 Antibiot. Khimioter. pmid:19441654
Kal'tianis PA [Cycloserine in the treatment of pyelonephritis against relapse]. 1985 Antibiot. Med. Biotekhnol. pmid:3901915
SCHLOSS J and ISMAIL Z Cycloserine and isoniazid in childhood tuberculous infections. 1960 Antibiotic Med Clin Ther (New York) pmid:14442915
ACETO JN and COVERT DF Observations on cycloserineisoniazid in pulmonary tuberculosis. 1960 Antibiotic Med Clin Ther (New York) pmid:13681189
De Stasio A and Puccini G [Observations of the activity of capreomycin, cicloserine, kanamycin and streptomycin to clinical isolates of Mycobacterium tubercolosis]. 1968 Antibiotica pmid:4984521
Cantani A et al. [D-cycloserine and germination of Bacillus cereus spores]. 1974 Antibiotica pmid:4220027
Dorozhkova IR and Volk AV [Frequency of Mycobacterium tuberculosis L-form induction under the influence of cycloserine and its combinations with other drugs]. 1972 Antibiotiki pmid:4120084
SMOLNIKOVA NM [DISTRIBUTION OF D,L- AND D-CYCLOSERINE IN THE WHITE MOUSE]. 1963 Antibiotiki pmid:14076091
KheÄ­fets LB and Kozlova NE [Quantitative evaluation of the effect of depression of Mycobacterium tuberculosis intracellular multiplication under the influence of antibacterial preparations]. 1975 Antibiotiki pmid:817645
Cheslak I et al. [Decomposition of cycloserine in the process of chemical treatment of culture fluid]. 1967 Antibiotiki pmid:5593966
Ivanova ES [Concentration of ethionamide and cycloserine in the blood of the patients with pulmonary tuberculosis]. 1967 Antibiotiki pmid:4968419
Shmelev NA et al. [Comparative clinical electroencephalographic study of cycloserine and terizidon tolerance]. 1975 Antibiotiki pmid:1091207
UTKIN VV [Cycloserine in experimental tuberculosis in monkeys]. 1962 Antibiotiki pmid:13995570
Bialik IB [Kanamycin and florimycin in the clinical course of pulmonary tuberculosis]. 1971 Antibiotiki pmid:4326728
Kuznetsov VD and Rodionova EG [Preservation of some Actinomycetes--producers of antibiotics by different methods]. 1970 Antibiotiki pmid:4321152
Krepak OM and Storozhev IA [Changes in the functional state of the liver in animals under the action of streptomycin, D-cycloserine, kanamycin and florimycin. Effect of antibiotics on alkaline phosphatase activity]. 1970 Antibiotiki pmid:4321154
Krepak OM [The effect of D-cycloserin and florimycin on the activity of glutamate aspartate transaminase in blood serum of albino mice]. 1966 Antibiotiki pmid:4293568
Mkrtchian SV [Development of resistance of Mycobacterium tuberculosis to cycloserine, ethionamide, kanamycin, florimycin in experiments in vitro]. 1968 Antibiotiki pmid:4303355
KIVMAN GIa and SMOLNIKOVA NM [CLEARANCE OF THE BLOOD SERUM FROM D- AND D,L-CYCLOSERINE IN THE RABBIT]. 1964 Antibiotiki pmid:14319176
KARTSEVA VD and BRUNS BP [A COLORIMETRIC METHOD FOR THE DETERMINATION OF CYCLOSERINE]. 1965 Antibiotiki pmid:14294439
Kagramanov AI et al. [Concentration of cycloserine in the blood of patients with pulmonary tuberculosis]. 1969 Antibiotiki pmid:4889841
Belogurova VP and Ivanitskaia NN [Viability of the drug resistant Mycobacterium tuberculosis (study by the proportion method)]. 1970 Antibiotiki pmid:5497632
Iakhontova LF et al. [Sorption of cycloserine by H-form of sulfurcation exchange resin]. 1970 Antibiotiki pmid:5497648
Shmelev NA and Shabalova LN [Changes in the bioelectric activity of the brain in patients with pulmonary tuberculosis during intolerance cycloserine]. 1970 Antibiotiki pmid:5501372
MITROFANOV VS and RAZUMOVA IL [Morphological analysis of the effect of cycloserine on experimental tuberculosis in white mice]. 1960 Mar-Apr Antibiotiki pmid:14423030
RudoÄ­ NM et al. [Restoration of drug sensitivity in Mycobacterium tuberculosis to streptomycin and isoniazid during treatment with preparations of the 1st series]. 1970 Antibiotiki pmid:4993044